drugset / Trial / NCT02538003
To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess safety, tolerability of LCB01-0371 after fasting/non-fasting food taken in healthy male subjects.
Timeline
- Start
- 2015-09
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Delpazolid | Small molecule | 800 mg | — |
Indications
No indication recorded.